Mayo Clinic Proceedings Home

Risk of Stroke and Myocardial Infarction After Herpes Zoster in Older Adults in a US Community Population

Published:December 15, 2015DOI:https://doi.org/10.1016/j.mayocp.2015.09.015

      Abstract

      Objective

      To assess the risk of stroke and myocardial infarction (MI) after herpes zoster in a US community population of older adults.

      Patients and Methods

      We performed a community cohort study (January 1, 1986, to October 1, 2011) comparing the risk of stroke and MI in 4862 adult residents of Olmsted County, Minnesota, 50 years and older with and without herpes zoster and 19,433 sex- and age-matched individuals with no history of herpes zoster. Odds ratios are presented for MI and stroke at 3, 6, 12, and 36 months after index herpes zoster plus hazard ratios for long-term risk (up to 28.6 years).

      Results

      Individuals with herpes zoster had more risk or confounding factors for MI and stroke, suggesting that they had worse health status overall. When controlling for the multiple risk factors, those with herpes zoster were at increased risk for stroke at 3 months after herpes zoster compared with those without a history of herpes zoster (odds ratio, 1.53; 95% CI, 1.10-2.33; P=.04). The association between herpes zoster and MI at 3 months was not robust across analytic methods. Herpes zoster was not associated with an increased risk of stroke or MI at any point beyond 3 months.

      Conclusions

      Herpes zoster was associated with only a short-term increased risk of stroke, which may be preventable with the prevention of herpes zoster.
      To read this article in full you will need to make a payment

      References

        • Cohen J.I.
        Clinical practice: herpes zoster.
        N Engl J Med. 2013; 369: 255-263
        • Nagel M.
        • Gilden D.
        Editorial commentary: varicella zoster virus infection: generally benign in kids, bad in grown-ups.
        Clin Infect Dis. 2014; 58: 1504-1506
        • Kawai K.
        • Gebremeskel B.G.
        • Acosta C.J.
        Systematic review of incidence and complications of herpes zoster: towards a global perspective.
        BMJ Open. 2014; 4: e004833
        • Yawn B.P.
        • Gilden D.
        The global epidemiology of herpes zoster.
        Neurology. 2013; 81: 928-930
        • Harpaz R.
        • Ortega-Sanchez I.R.
        • Seward J.F.
        Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization Practices (ACIP).
        MMWR Recomm Rep. 2008; 57: 1-30
        • Yawn B.P.
        • Saddier P.
        • Wollan P.C.
        • St Sauver J.L.
        • Kurland M.J.
        • Sy L.S.
        A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction.
        Mayo Clin Proc. 2007; 82: 1341-1349
        • Nagel M.A.
        • Traktinskiy I.
        • Azarkh Y.
        • et al.
        Varicella zoster virus vasculopathy: analysis of virus-infected arteries.
        Neurology. 2011; 77: 364-370
        • Gilbert G.J.
        Herpes zoster ophthalmicus and delayed contralateral hemiparesis: relationship of the syndrome to central nervous system granulomatous angiitis.
        JAMA. 1974; 229: 302-304
        • Yawn B.P.
        • Wollan P.C.
        • St Sauver J.L.
        • Butterfield L.C.
        Herpes zoster eye complications: rates and trends.
        Mayo Clin Proc. 2013; 88: 562-570
        • Gilden D.
        Association of varicella zoster virus with giant cell arteritis.
        Monoclon Antib Immunodiagn Immunother. 2014; 33: 168-172
        • Kang J.H.
        • Ho J.D.
        • Chen Y.H.
        • Lin H.C.
        Increased risk of stroke after a herpes zoster attack: a population-based follow-up study.
        Stroke. 2009; 40: 3443-3448
        • Breuer J.
        • Pacou M.
        • Gautier A.
        • Brown M.M.
        Herpes zoster as a risk factor for stroke and TIA: a retrospective cohort study in the UK.
        Neurology. 2014; 83: e27-e33
        • Langan S.M.
        • Minassian C.
        • Smeeth L.
        • Thomas S.L.
        Risk of stroke following herpes zoster: a self-controlled case-series study.
        Clin Infect Dis. 2014; 58: 1497-1503
        • Sreenivasan N.
        • Basit S.
        • Wohlfahrt J.
        • et al.
        The short- and long-term risk of stroke after herpes zoster: a nationwide population-based cohort study.
        PLoS One. 2013; 8: e69156
        • Lin H.C.
        • Chien C.W.
        • Ho J.D.
        Herpes zoster ophthalmicus and the risk of stroke: a population-based follow-up study.
        Neurology. 2010; 74: 792-797
        • Yawn B.P.
        • Yawn R.A.
        • Geier G.R.
        • Xia Z.
        • Jacobsen S.J.
        The impact of requiring patient authorization for use of data in medical records research.
        J Fam Pract. 1998; 47: 361-365
        • Jacobsen S.J.
        • Xia Z.
        • Campion M.E.
        • et al.
        Potential effect of authorization bias on medical record research.
        Mayo Clin Proc. 1999; 74: 330-338
        • St Sauver J.L.
        • Grossardt B.R.
        • Yawn B.P.
        • Melton L.J.
        • Rocca W.A.
        Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project.
        Am J Epidemiol. 2011; 173: 1059-1068
        • St Sauver J.L.
        • Grossardt B.R.
        • Yawn B.P.
        • Melton L.J.
        • Pankratz J.J.
        • Brue S.M.
        • Rocca W.A.
        Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system.
        Int J Epidemiol. 2012; 41: 1614-1624
        • Rocca W.A.
        • Yawn B.P.
        • St Sauver J.L.
        • Grossardt B.R.
        • Melton L.J.
        History of the Rochester Epidemiology Project: half a century of medical records linkage in a US population.
        Mayo Clin Proc. 2012; 87: 1202-1213
        • St Sauver J.L.
        • Grossardt B.R.
        • Leibson C.L.
        • Yawn B.P.
        • Melton L.J.
        • Rocca W.A.
        Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project.
        Mayo Clin Proc. 2012; 87: 151-160
        • Yawn B.P.
        • Itzler R.F.
        • Wollan P.C.
        • Pellissier J.M.
        • Sy L.S.
        • Saddier P.
        Health care utilization and cost burden of herpes zoster in a community population.
        Mayo Clin Proc. 2009; 84: 787-794
        • Marin M.
        • Yawn B.P.
        • Hales C.M.
        • Bailek S.
        • Harpaz R.
        Herpes zoster vaccine effectiveness and manifestations of herpes zoster and associated pain by vaccination status.
        Hum Vaccin Immunother. 2015; 11: 1157-1164
        • Yawn B.P.
        • Wollan P.C.
        • Kurland M.J.
        • St Sauver J.L.
        • Saddier P.
        Herpes zoster recurrences more frequent than previously reported.
        Mayo Clin Proc. 2011; 86: 88-93
        • Yawn B.P.
        • Wollan P.
        • St Sauver J.
        Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they?.
        Am J Epidemiol. 2011; 174: 1054-1061
        • Yawn B.P.
        • Wollan P.C.
        • Yawn R.A.
        • Jacobsen S.J.
        • Roger V.
        The gender specific frequency of risk factor and CHD diagnoses prior to incident MI: a community study.
        BMC Fam Pract. 2007; 8: 18
        • Johnson R.W.
        • Rice A.S.C.
        Postherpetic neuralgia.
        N Engl J Med. 2014; 371: 1526-1533
        • US Department of Health and Human Services
        Multiple Chronic Conditions: A Strategic Framework: Optimum Health and Quality of Life for Individuals With Multiple Chronic Conditions.
        US Dept of Health and Human Services, Washington, DCDecember 2010
        • Cohen J.W.
        • Cohen S.B.
        • Banthin J.S.
        The medical expenditure panel survey: a national information resource to support healthcare cost research and inform policy and practice.
        Med Care. 2009; 47: S44-S50
        • Goodman R.A.
        • Posner S.F.
        • Huang E.S.
        • Parekh A.K.
        • Koh H.K.
        Defining and measuring chronic conditions: imperatives for research, policy, program, and practice.
        Prev Chronic Dis. 2013; 10: E66
      1. Bobo W, Rocca W, St Sauver J, Grosshart B, Yawn BP. Physical and mental multi-morbidity in a geographically define community population. Psychosom Med. In press.

        • Gustad L.T.
        • Laugsand L.E.
        • Janszky I.
        • Dalen H.
        • Bjerkeset O.
        Symptoms of anxiety and depression and risk of acute myocardial infarction: the HUNT 2 study.
        Eur Heart J. 2014; 35: 1394-1403
        • Hebert P.L.
        • Geiss L.S.
        • Tierney E.F.
        • Engelgau M.M.
        • Yawn B.P.
        • Mcbean A.M.
        Identifying persons with diabetes using Medicare claims data.
        Am J Med Qual. 1999; 14: 270-277
        • Go A.S.
        • Mozaffarian D.
        • Roger V.L.
        • et al.
        Heart disease and stroke statistics–2014 update: a report from the American Heart Association.
        Circulation. 2014; 129: e28-e292
        • Grambsch P.
        • Therneau T.
        Proportional hazards tests and diagnostics based on weighted residuals.
        Biometrika. 1994; 81: 515-526
      2. Chamberlain AM, Finney Rutten LJ, Manemann SM, et al. Frailty trajectories in an elderly population-based cohort. J Am Geriatr Soc. In press.

        • Yende S.
        • Angus D.C.
        • Ali I.S.
        • et al.
        Influence of comorbid conditions on long-term mortality after pneumonia in older people.
        J Am Geriatr Soc. 2007; 55: 518-525
      3. Case records of the Massachusetts General Hospital: weekly clinicopathological exercises: case 36–1996: a 37-year-old man with AIDS, neurologic deterioration, and multiple hemorrhagic cerebral lesions.
        N Engl J Med. 1996; 335: 1587-1595
        • Nagel M.A.
        • Lenggenhager D.
        • White T.
        • et al.
        Disseminated VZV infection and asymptomatic VZV vasculopathy after steroid abuse.
        J Clin Virol. 2015; 66: 72-75
        • Nagel M.A.
        • Traktinskiy I.
        • Stenmark K.R.
        • Frid M.G.
        • Choe A.
        • Gilden D.
        Varicella-zoster virus vasculopathy: immune characteristics of virus-infected arteries.
        Neurology. 2013; 80: 62-68
        • Corrales-Medina V.F.
        • Alvarez K.N.
        • Weissfeld L.A.
        • et al.
        Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease.
        JAMA. 2015; 313: 264-274
        • Smeeth L.
        • Thomas S.L.
        • Hall A.J.
        • Hubbard R.
        • Farrington P.
        • Vallance P.
        Risk of myocardial infarction and stroke after acute infection or vaccination.
        N Engl J Med. 2004; 351: 2611-2618